6 天之前 · Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...

3 天之前 · This week’s episode of The Top Line dives into the discussion, featuring Fierce Biotech’s Gabrielle Masson as moderator, joined by Septerna CEO and co-founder Jeffrey Finer, M.D., Ph.D ...

1 天前 · Jan. 29 - I-Mab: After announcing a pipeline restructure earlier in the month, I-Mab’s has reduced its workforce by around 27%. Story. Jan. 28 - Zentalis Pharmaceuticals: In hopes of extending ...

1 天前 · Welcome to Fierce Biotech's Fundraising Tracker for 2025. January. Jan. 28—Atalanta Therapeutics Series: B Amount: $97 million Investors: EQT Life Sciences, Sanofi Ventures, F-Prime Capital ...

2024年10月28日 · Kadimastem shareholders signing off on a merger with NLS that would enable the cell therapy developer to recover from last year’s thwarted attempt.

2024年12月6日 · To learn more about the topics in this episode: Septerna's $288M IPO is another sign of the market warming to biotech investment; BioAge brings in almost $200M from IPO as obesity biotech joins Nasdaq

2025年1月28日 · Kadimastem shareholders signing off on a merger with NLS that would enable the cell therapy developer to recover from last year’s thwarted attempt.

One of our Fierce 15 honorees dove deep into the ocean for inspiration from the sea squirt to develop new human therapeutics. Another thought the adorable 13-lined ground squirrel, with its polka ...

2025年1月2日 · A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

2024年12月23日 · Fierce Biotech's Gabrielle Masson presents Fierce 15 at NYSE. Unveiling the Fierce 15 list is always a high point of our year, as we run down the 15 companies breaking barriers and defining the ...